Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 18 Source: CRO
- €20 million turnover
-
€32.5 million
profit - 52 employees
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
- 3 more years available »
Ranking
By Turnover
(€20 million)- 883rd in Top Companies
- 95th in Health
By Employees
(52)- 829th in Top Companies
- 89th in Health
- 52
- €20 million
Employees
- Colm Healy Vice President}
Latest News
- 4:09pm Avant Money’s Spanish owner forecasts higher loan growth
- 3:34pm Court must rehear part of 25-year-old VRT case about valuing imported cars
- 3:14pm Aryzta investors told to convert Irish stock or risk a limited market
- 2:26pm Hungary becomes first EU state to approve Russia’s Covid vaccine
- 1:41pm Cairn Homes’ RTÉ site plans delayed after court quashes planning permission